Annette H M van der Helm-van Mil Selected Research

Tenosynovitis

10/2022	Intermetatarsal Bursitis, a Novel Feature of Juxtaarticular Inflammation in Early Rheumatoid Arthritis Related to Clinical Signs: Results of a Longitudinal Magnetic Resonance Imaging Study.
12/2016	Magnetic resonance imaging-detected inflammation is associated with functional disability in early arthritis-results of a cross-sectional study.
1/2016	MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF.
5/2015	Aiming for a simpler early arthritis MRI protocol: can Gd contrast administration be eliminated?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Annette H M van der Helm-van Mil Research Topics

Disease

62	Rheumatoid Arthritis 11/2022 - 01/2005
34	Arthritis (Polyarthritis) 01/2022 - 10/2005
21	Inflammation (Inflammations) 11/2022 - 01/2013
11	Synovitis 10/2022 - 05/2015
9	Arthralgia (Joint Pain) 01/2022 - 09/2013
4	Tenosynovitis 10/2022 - 05/2015
3	Fatigue 11/2022 - 01/2015
3	Osteitis 10/2022 - 01/2016
3	Autoimmune Diseases (Autoimmune Disease) 11/2020 - 10/2011
3	Disease Progression 08/2017 - 01/2005
2	Reactive Arthritis (Reiter Disease) 11/2015 - 01/2010
2	Bone Resorption 05/2014 - 05/2013
2	Infections 07/2010 - 01/2010
1	COVID-19 01/2022
1	Sarcoidosis (Schaumann Disease) 01/2021
1	Systemic Scleroderma (Systemic Sclerosis) 07/2018
1	Chronic Disease (Chronic Diseases) 08/2017
1	Leprosy (Hansen's Disease) 08/2017
1	Myalgia 05/2016
1	Edema (Dropsy) 01/2016
1	Psoriatic Arthritis 11/2015
1	Experimental Arthritis 05/2013
1	Dyslipidemias (Dyslipidemia) 01/2013
1	Disease Susceptibility (Diathesis) 01/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2013
1	Neoplasms (Cancer) 01/2010
1	Sepsis (Septicemia) 01/2010

Drug/Important Bio-Agent (IBA)

23	AutoantibodiesIBA 01/2022 - 05/2005
21	AntibodiesIBA 11/2020 - 01/2005
20	Antirheumatic Agents (DMARD)IBA 11/2022 - 08/2008
17	Anti-Citrullinated Protein AntibodiesIBA 01/2022 - 01/2005
16	Proteins (Proteins, Gene)FDA Link 11/2020 - 01/2005
9	EpitopesIBA 01/2022 - 05/2005
7	Peptides (Polypeptides)IBA 10/2016 - 09/2013
6	Rheumatoid FactorIBA 11/2018 - 08/2009
6	C-Reactive ProteinIBA 01/2018 - 09/2013
5	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 02/2007
5	acetyl 4-aminosalicylic acidIBA 01/2022 - 08/2009
5	HLA-DRB1 Chains (HLA DRB1)IBA 01/2015 - 10/2005
4	amsonic acid (DAS)IBA 11/2022 - 06/2012
4	Biological ProductsIBA 06/2021 - 08/2009
4	cyclic citrullinated peptideIBA 08/2009 - 01/2005
3	Biomarkers (Surrogate Marker)IBA 10/2018 - 02/2016
3	AntigensIBA 02/2012 - 08/2011
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2017
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 05/2005
2	ametantrone (HAQ)IBA 01/2020 - 12/2016
2	OsteoprotegerinIBA 05/2016 - 05/2014
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 05/2016 - 09/2013
2	GadoliniumIBA 05/2015 - 10/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2014 - 07/2010
2	Pharmaceutical PreparationsIBA 06/2012 - 05/2005
2	TNF Receptor-Associated Factor 1IBA 01/2010 - 09/2007
1	IMB 10IBA 10/2022
1	insulin receptor-related receptor (IRR)IBA 05/2022
1	Contrast MediaIBA 01/2022
1	CC ChemokinesIBA 01/2021
1	Insulin-Like Growth Factor I (IGF-1)IBA 11/2020
1	ChemokinesIBA 11/2020
1	CytokinesIBA 11/2020
1	Anti-Idiotypic AntibodiesIBA 12/2017
1	Interferon-gamma (Interferon, gamma)IBA 08/2017
1	IgG Receptors (Fc gamma RI)IBA 02/2016
1	ORALIT (ORS)IBA 01/2016
1	CitrullineIBA 10/2015
1	AllergensIBA 10/2015
1	Amino Acids FDA Link 01/2015
1	AcidsIBA 01/2015
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 05/2014
1	LigandsIBA 05/2014
1	CollagenIBA 08/2013
1	pyridinolineIBA 08/2013
1	Peptide Hydrolases (Proteases)FDA Link 05/2013
1	Pattern Recognition ReceptorsIBA 05/2013
1	Cathepsin KIBA 05/2013
1	Apolipoproteins E (ApoE)IBA 01/2013
1	LipidsIBA 01/2013
1	ApolipoproteinsIBA 01/2013
1	SalicylatesIBA 07/2010
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2010
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2010
1	VimentinIBA 08/2009
1	HLA-DR Antigens (HLA-DR)IBA 12/2007
1	HLA-DR3 Antigen (HLA DR3 Antigen)IBA 10/2005
1	Transcription Factors (Transcription Factor)IBA 05/2005

Therapy/Procedure

10	Therapeutics 11/2022 - 08/2009
1	Aftercare (After-Treatment) 11/2022
1	Oral Administration 01/2022